Tumour cell proliferation, but not apoptosis, predicts survival in B-cell non-Hodgkin's lymphomas.

por Stokke, T., Smeland, E. B., Kvaløy, S., Holte, H.
Publicado 1998

Post-treatment parenthood in Hodgkin's lymphoma survivors

por Kiserud, C E, Fosså, A, Holte, H, Fosså, S D
Publicado 2007

High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells

por Blystad, AK, Holte, H, Kvaløy, S, Smeland, E, Delabie, J, Kvalheim, G
Publicado 2001

Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapy

por Kiserud, C E, Fosså, A, Bjøro, T, Holte, H, Cvancarova, M, Fosså, S D
Publicado 2009

Proliferation and apoptosis in malignant and normal cells in B-cell non-Hodgkin's lymphomas.

por Stokke, T., Holte, H., Smedshammer, L., Smeland, E. B., Kaalhus, O., Steen, H. B.
Publicado 1998

Valvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal study

por Wethal, T, Lund, M-B, Edvardsen, T, Fosså, S D, Pripp, A H, Holte, H, Kjekshus, J, Fosså, A
Publicado 2009

Loss of chromosome 11q21–23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma

por Stokke, T, DeAngelis, P, Smedshammer, L, Galteland, E, Steen, H B, Smeland, E B, Delabie, J, Holte, H
Publicado 2001

Entourage: the immune microenvironment following follicular lymphoma

por Wahlin, B E, Sander, B, Christensson, B, Østenstad, B, Holte, H, Brown, P D, Sundström, C, Kimby, E
Publicado 2012

Alternative splicing discriminates molecular subtypes and has prognostic impact in diffuse large B-cell lymphoma

por Leivonen, S-K, Taskinen, M, Cervera, A, Karjalainen-Lindsberg, M-L, Delabie, J, Holte, H, Lehtonen, R, Hautaniemi, S, Leppä, S
Publicado 2017

Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study

por Pauly, F, Fjordén, K, Leppä, S, Holte, H, Björkholm, M, Fluge, Ø, Møller Pedersen, L, Eriksson, M, Isinger-Ekstrand, A, Borrebaeck, C A K, Jerkeman, M, Wingren, C
Publicado 2016

P1135: SUBCUTANEOUS EPCORITAMAB IN COMBINATION WITH RITXUIMAB + LENALIDOMIDE IN RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: PHASE 1/2 TRIAL UPDATE

por Belada, D., Leppä, S., Wahlin, B. E., Nijland, M., Christensen, J. H., de Vos, S., Holte, H., Linton, K. M., Abbas, A., Wang, L., Dinh, M., Elliott, B., Falchi, L.
Publicado 2022